The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 8,782,200 | 2,380,000 | SH | SOLE | 2,380,000 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 3,990,450 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 11,221,243 | 1,347,088 | SH | SOLE | 1,347,088 | 0 | 0 | |||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 2,874,400 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | PUT | 10806X952 | 3,440,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | ||
| BRUUSH ORAL CARE INC | *W EXP 08/03/202 | 11750K120 | 28,846 | 360,579 | SH | SOLE | 360,579 | 0 | 0 | |||
| CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 13,188 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 6,450 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 11,718,100 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | |||
| CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 56,700 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 2,782,400 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | |||
| COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 4,247 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | |||
| COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 513,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| COLOMBIER ACQUISITION CORP | *W EXP 99/99/999 | 19533H116 | 12,791 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 2,432,700 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 7,322,287 | 668,702 | SH | SOLE | 668,702 | 0 | 0 | |||
| DIGITAL HEALTH ACQUISITION C | *W EXP 11/02/202 | 253893119 | 9,990 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| DIRECT DIGITAL HOLDINGS INC | *W EXP 02/15/202 | 25461T113 | 108,000 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | |||
| DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 582,583 | 60,876 | SH | SOLE | 60,876 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 1,743,750 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | |||
| FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 776,340 | 227,000 | SH | SOLE | 227,000 | 0 | 0 | |||
| FIBROGEN INC | CALL | 31572Q908 | 94,500 | 35,000 | SH | Call | SOLE | 35,000 | 0 | 0 | ||
| FIBROGEN INC | PUT | 31572Q958 | 45,900 | 17,000 | SH | Put | SOLE | 17,000 | 0 | 0 | ||
| GRI BIO INC | COM | 3622AW106 | 5,011,966 | 1,179,286 | SH | SOLE | 1,179,286 | 0 | 0 | |||
| HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 4,200 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
| HARBOR CUSTOM DEVELOPMENT IN | *W EXP 10/07/202 | 41150T124 | 5,720 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 5,274,594 | 149,889 | SH | SOLE | 149,889 | 0 | 0 | |||
| IMMUNOGEN INC | COM | 45253H101 | 9,151,950 | 485,000 | SH | SOLE | 485,000 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 665,847 | 35,100 | SH | SOLE | 35,100 | 0 | 0 | |||
| INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 3,572,380 | 323,000 | SH | SOLE | 323,000 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM | 471871103 | 3,929,160 | 2,868,000 | SH | SOLE | 2,868,000 | 0 | 0 | |||
| JEFFS BRANDS LTD | *W EXP 08/26/202 | M61472110 | 55,721 | 480,770 | SH | SOLE | 480,770 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,324,600 | 740,000 | SH | SOLE | 740,000 | 0 | 0 | |||
| KODIAK SCIENCES INC | COM | 50015M109 | 1,035,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| LIGHTNING EMOTORS INC | *W EXP 05/18/202 | 53228T119 | 991 | 32,608 | SH | SOLE | 32,608 | 0 | 0 | |||
| MARPAI INC | CL A COM NEW | 571354208 | 201,520 | 117,848 | SH | SOLE | 117,848 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | CALL | 59045L906 | 658,329 | 200,100 | SH | Call | SOLE | 200,100 | 0 | 0 | ||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 4,488,000 | 88,000 | SH | SOLE | 88,000 | 0 | 0 | |||
| MURPHY CANYON ACQUISITION CO | *W EXP 01/25/202 | 626642110 | 4,580 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| NEXALIN TECHNOLOGY INC | *W EXP 09/15/202 | 65345B110 | 11,550 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | |||
| NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 97,200 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
| NLS PHARMACEUTICS LTD | *W EXP 02/02/202 | H57830111 | 21,400 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 62,550 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 2,799,300 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | |||
| ONFOLIO HOLDINGS INC | *W EXP 01/02/202 | 68277K124 | 40,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| OPY ACQUISITION CORP I | COM CL A | 671005106 | 512,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| OPY ACQUISITION CORP I | *W EXP 09/22/202 | 671005114 | 4,255 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| PEPPERLIME HEALTH ACQUSTN CO | CLASS A ORD SHS | G70021103 | 1,045,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| PEPPERLIME HEALTH ACQUSTN CO | *W EXP 10/01/202 | G70021111 | 8,416 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | |||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 2,970,426 | 207,432 | SH | SOLE | 207,432 | 0 | 0 | |||
| POLISHED COM INC | COM | 28252C109 | 264,982 | 576,048 | SH | SOLE | 576,048 | 0 | 0 | |||
| POLISHED COM INC | *W EXP 06/02/202 | 28252C117 | 396,138 | 6,103,824 | SH | SOLE | 6,103,824 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 1,638,750 | 1,425,000 | SH | SOLE | 1,425,000 | 0 | 0 | |||
| PROSOMNUS INC | *W EXP 04/20/202 | 50535E116 | 12,075 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 4,229,811 | 41,485 | SH | SOLE | 41,485 | 0 | 0 | |||
| RELATIVITY ACQUISITION CORP | *W EXP 12/15/202 | 75944B114 | 0 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| REPLIMUNE GROUP INC | COM | 76029N106 | 3,018,600 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 3,206,560 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | |||
| SELINA HOSPITALITY PLC | *W EXP 10/27/202 | G8059B119 | 4,331 | 101,439 | SH | SOLE | 101,439 | 0 | 0 | |||
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 4,539 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | |||
| TC BIOPHARM HOLDINGS PLC | *W EXP 02/08/202 | 87807D111 | 809 | 18,823 | SH | SOLE | 18,823 | 0 | 0 | |||
| TG VENTURE ACQUISITION CORP | *W EXP 08/15/202 | 87251T117 | 4,500 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 1,926,000 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
| WEARABLE DEVICES LTD | *W EXP 09/14/202 | M97838110 | 282,320 | 1,411,600 | SH | SOLE | 1,411,600 | 0 | 0 | |||
| WESTERN ACQSTN VENTURES CORP | COM | 95758L107 | 1,041,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| WESTERN ACQSTN VENTURES CORP | *W EXP 09/01/202 | 95758L115 | 6,090 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 8,778,000 | 228,000 | SH | SOLE | 228,000 | 0 | 0 | |||
| XTANT MED HLDGS INC | COM NEW | 98420P308 | 5,791,007 | 6,227,559 | SH | SOLE | 6,227,559 | 0 | 0 | |||